Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Telesis Bio Inc chart...

About the Company

sgi-dna, a wholly owned subsidiary of synthetic genomics inc., provides genomic solutions to advance scientific discovery. sgi-dna’s ever expanding suite of products, services, reagents, bioinformatics tools and instrumentation enables scientists to discover, design and build novel solutions for basic research, as well as for biomedical and industrial applications. sgi-dna’s genomic services include whole genome sequencing, dna synthesis, library design, bioinformatics, cell engineering, and plasmid dna cloning and purification. sgi-dna’s reagents include a complete suite of gibson assembly® and site directed mutagenesis kits as well as optimized cell lines such as vmax™ a novel, fast growing host system for molecular biology. to further enable synthetic biology workflows, sgi-dna offers the bioxp™ 3200 system. this fully automated genomics workstation allows the creation of double stranded dna fragments, automated cloning, as well as next generation sequencing dna library preparation.

Exchange

NASDAQ

Website

sgidna.com

$30M

Total Revenue

76

Employees

$16M

Market Capitalization

0.00

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $TBIO News

Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket

3d ago, source:

Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported ...

Patient Square Capital to acquire NanoString Technologies for $220M

on MSN ago, source:

NanoString Technologies (NSTGQ) has signed an agreement with Patient Square Capital, a leading healthcare investment firm, to ...

bluebird bio shares jump on first outcomes-based Medicaid deal for sickle cell therapy

on MSN ago, source:

bluebird bio ( NASDAQ: BLUE) is trading as much as +9% in premarket trading on Monday after it announced its first Medicaid ...

Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq Rules

7d ago, source:

Intelligent Bio Solutions Inc. ("INBS" or the "Company") (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that on March 8, ...

Springworks Therapeutics, Inc.

8mon ago, source:

View Springworks Therapeutics, Inc. SWTX stock quote prices, financial information, real-time forecasts, and company news from CNN.

Biotech Stock News Bite - Elicio Therapeutics, Inc. (Nasdaq: ELTX) Rises on Funding News

6h ago, source: Investor ideas

Investorideas.com ( Biotech Stock News Bites - Elicio Therapeutics, Inc. (Nasdaq: ELTX), a clinical-stage biotechnology ...

Which Is a Better Investment, Apellis Pharmaceuticals Inc or Avidity Biosciences Inc Stock?

6d ago, source: American Association of Individual Investors

Learn more about whether Apellis Pharmaceuticals Inc or Avidity Biosciences Inc is a better investment based on AAII's A+ ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...